ZRL-Ⅱ-A腔道介入治疗仪联合抗生素治疗盆腔炎性疾病后遗症  

ZRL-Ⅱ-A interventional therapy combined with antibiotics in the treatment of sequelae of pelvic inflammatory disease

作　　者：潘丽[1] 孙进[1] 罗明艳 冯坤[1] 陈虹[1] Pan Li;Sun Jin;Luo Mingyan;Feng Kun;Chen Hong(Department of Obstetrics and Gynecology,General Hospital of Chengdu Military Command,Chengdu,Sichuan,610083,China)

机构地区：[1]成都军区总医院妇产科,成都610083

出　　处：《西南国防医药》2018年第7期601-603,共3页Medical Journal of National Defending Forces in Southwest China

基　　金：国家自然科学基金青年项目(81501319);上海市卫计委科研基金面上项目(201540237)

摘　　要：目的探讨盆腔炎性疾病后遗症的有效治疗方法。方法选择盆腔炎性疾病后遗症患者64例,随机分为观察组和对照组,各32例。治疗组采用ZRL-Ⅱ-A腔道介入治疗仪联合抗生素治疗,对照组单用抗生素治疗,观察两组的临床疗效和复发率。结果治疗1个疗程后,治疗组病情程度评分为(4.87±0.67)分显著低于对照组(8.21±0.81)分(P<0.05);治疗组的治愈率和总有效率均明显高于对照组(P<0.05)。治疗3个月后,治疗组复发5例,对照组复发13例,两组比较有显著差异(P<0.05)。结论腔道介入联合抗生素治疗可有效提高盆腔炎性疾病后遗症的疗效,降低复发率。Objective To explore the effective treatment of sequelae of pelvic inflammatory disease（PID）. Methods A total of 64 patients with sequelae of PID were randomly divided into an observation group and a control group（n =32, respectively）. The treatment group was treated with ZRL-Ⅱ-A interventional therapy combined with antibiotics, while the control group was treated with antibiotics only. The clinical efficacy and recurrence rate between the two groups were observed. Results After one course of treatment, the severity score of the treatment group（4.87±0.67） was significantly lower than that of the control group（8.21±0.81）（P〈0.05）, and the cure rate and total effective rate of the treatment group were significantly higher than those in the control group（P〈0.05）. After three months of treatment, five cases recurred in the treatment group and 13 ones in the control group, showing a significant difference between the two groups（P〈0.05）. Conclusion Interventional therapy combined with antibiotic therapy can effectively improve the curative effect and reduce the recurrence rate of sequelae of PID.

关 键 词：腔道 介入治疗 盆腔炎性疾病后遗症 疗效 

分 类 号：R711[医药卫生—妇产科学]